This is a preview of subscription content, log in via an institution to check access.
Notes
The study was funded by Abbott Diabetes Care China.
Indirect costs were not included as patients were aged older than the age for retirement in China.
Reference
Zhao X, et al. Cost-Effectiveness of Flash Glucose Monitoring for the Management of Patients with Type 1 and Patients with Type 2 Diabetes in China. Diabetes Therapy : 23 Oct 2021. Available from: URL: https://doi.org/10.1007/s13300-021-01166-z
Rights and permissions
About this article
Cite this article
Continuous glucose monitoring cost effective for T1DM and T2DM patients in China. PharmacoEcon Outcomes News 890, 5 (2021). https://doi.org/10.1007/s40274-021-08128-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-021-08128-0